Lots of Patients With Cancer, Cancer Survivors Use But Don’t Report Complementary/Alternative Medicine Therapies

JAMA Oncology 


Media advisory: To contact corresponding author Nina N. Sanford, M.D., email Patrick McGee at Patrick.McGee@UTSouthwestern.edu. The full study is linked to this news release.

Embed this link to provide your readers free access to the full-text article: This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/2730130?guestAccessKey=b931cef7-147d-429b-80e7-b3d32b5182eb&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=041119


Bottom Line: This study used data from a nationwide survey to estimate how many patients with cancer and cancer survivors use complementary and alternative medicines (CAMS) in addition to or instead of conventional therapies, and how many don’t disclose that to their physicians. Among about 3,100 survey participants reporting a history of cancer, 33.3% used CAMs in the past 12 months and the most commonly used were herbal supplements (35.8%), followed by other modalities that include chiropractic or osteopathic manipulation (25.4%); massage (14.1%); yoga/tai chi/qigong (7.6%); mantra/mindfulness/spiritual meditation (6.9%); special diets (2.9%); and acupuncture (2.0%). Among the 1,023 participants who reported using CAM, 288 (29.3%) didn’t disclose that to their physicians. Many participants said they didn’t disclose their CAM use because physicians didn’t ask or they didn’t think their physicians needed to know. Considering the high proportion of patients with cancer and cancer survivors using CAM, there needs to be more study of its use on cancer outcomes.

Authors: Nina N. Sanford, M.D., of University of Texas Southwestern, Dallas, and coauthors



Editor’s Note: The article contains conflict of interest and funding/support disclosures. Please see the articles for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.

#  #  #

For more information, contact JAMA Network Media Relations at 312-464-JAMA (5262) or email mediarelations@jamanetwork.org.